Applied Medical v. U.S. Surgical
This article was originally published in The Gray Sheet
Executive Summary
Tyco unit files motion to stay Oct. 15 central California federal district court order enjoining the sale of trocars using Applied Medical's '553 patent, including VersaStep, VersaPort, VisiPort, BluntPort and S.D. Port devices. Tyco also has appealed the enjoinment. The court determined in 2000 that Tyco infringed two other Applied Medical trocar patents (1"The Gray Sheet" July 24, 2000, In Brief). A trial is set for April 2003 to determine damages for past infringement of all three patents...
You may also be interested in...
Applied Medical v. U.S. Surgical
Tyco unit permanently enjoined from selling trocars using Applied Medical's '553 patent, including VersaStep, VersaPort, VisiPort, BluntPort and S.D. Port devices, effective Nov. 1, after central California federal appeals court denies Tyco's motion to stay injunction (1"The Gray Sheet" Oct. 28, 2002, In Brief). An April 2003 trial will determine damages...
Applied Medica
Tyco's U.S. Surgical division infringed two of Applied's patents covering the Universal Seal technology for minimally invasive surgery, the U.S. District Court for the Central District of California determines July 6 in granting an order for partial summary judgment. The trial is expected to take place in the first quarter of 2001. Applied Medica is seeking an injunction on the infringed products in addition to damages
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.